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INTRODUCTION 
                                                          
 
   Ischemic heart disease are becoming  progressively commoner in the 
younger persons of third and fourth decade. Myocardial infarction is the 
irreversible death of heart muscle secondary to lack of blood(oxygen) 
supply. Patient may present with chest pain, breathlessness, fatigue, 
excessive sweating and palpitation. ECG is the most  important tool in the 
initial evaluation and triage of patients in whom an acute coronary 
syndrome such as myocardial infarction is suspected. ECG is confirmatory 
of diagnosis in approximately 80% of cases. Other supportive evidence in 
the diagnosis of myocardial infarction is cardiac biomarkers and cardiac 
imaging.  When patients with prolonged ischemic discomfort at rest are 
first seen, the working clinical diagnosis is that they are suffering from an 
acute coronary syndrome. The lead 12 ECG is a pivotal diagnostic and 
triage tool because it is at the center of the decision pathway for 
management. It permits distinction of those patients presenting with ST 
elevation MI from those presenting without STEMI.  Serum cardiac 
biomarkers are obtained to distinguish unstable angina from NSTEMI and 
to assess the magnitude of STEMI. 
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   STEMI usually occurs when coronary blood flow decreases  abruptly 
after a thrombotic occlusion of a coronary artery previously affected by 
atherosclerosis. Slowly developing, high grade coronary artery stenosis do not 
typically precipitate STEMI because of the development of rich collaterals. 
Serum cholinesterase is an enzyme that deacetylates acetyl choline to 
choline and acetic acid at high substrate level. The active centre of the enzyme 
contains both anionic and esteric site. Some studies have concluded that 
earlier and rapid fall in serum cholinesterase level of myocardial infarction 
patients resulted in a grave prognosis. Hence the association between serum 
cholinesterase in acute myocardial infarction and its use as prognostic marker 
is studied. 
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AIM OF THE STUDY 
 
 
 To study the incidence, levels and patterns of serum cholinesterase 
activity in acute myocardial infarction. 
 To assess the relationship between the rise and fall of serum 
cholinesterase in myocardial infarction 
 To determine the prognosis with relation to changing trend of serum 
cholinesterase 
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REVIEW OF LITERATURE 
 
 
Heart is a muscular organ located in the middle mediastinum. On an 
average the size of the heart of an individual is about the size of their closed 
fist. It acts as a circulatory pump. It receives deoxygenated blood from the 
large veins named venacavae which pours the deoxygenated blood to the 
right chambers of the heart from where blood is pumped to the lungs. In 
the lung, blood is oxygenated and the oxygenated blood is brought by the 
pulmonary veins to the left chambers of the heart from where the blood is 
pumped to other parts of the body.  
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FEATURES OF THE HEART 
 
 
The human heart has four chambers namely right atrium, left atrium, 
right ventricle and left ventricle. The heart has interatrial and atrio-
ventricular groove externally which marks the division of chambers. The 
musculature of the atria are thin and it has little force of contraction 
whereas the ventricle has thick musculature and it  can contract forcefully 
to propel the blood into pulmonary circulation in case of right ventricle and 
systemic circulation in case of left ventricle. The thickness of right 
ventricle to left ventricle is in the ratio of 1:3. The interatrial septum 
separates the left and right atrium. The interventricular septum separates 
the right and left ventricle. The interventricular septum is placed obliquely 
such that the upper part of the septum faces anteriorly and to the right 
whereas the lower part of the septum  faces backward and to the left. 
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LAYERS OF THE HEART 
Epicardium- it is the outermost covering of the heart mainly made up of   
connective tissue. 
Myocardium- it is the muscular layer of the heart 
Endocardium- it is the innermost lining of the heart containing the heart 
valves and endothelial lining. 
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ARTERIAL SUPPLY OF HEART 
 The heart is supplied by two coronary arteries arising from the 
ascending aorta. When compared the right coronary artery is small in 
majority of the individuals. 
 
RIGHT CORONARY ARTERY: 
 The right coronary artery arises from the anterior aortic sinus of the 
ascending aorta just above the aortic valve. 
 The right coronary artery runs forward in between the right auricle 
and pulmonary trunk and it descends in the right atrioventricular groove 
till it reaches the junction between the right and the inferior border of the 
heart. At the inferior border it turns posteriorly and runs in the groove 
where it ends by anastomosing with the left coronary artery 
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BRANCHES OF RCA: 
1. Right conus artery 
2. Atrial branches 
3. Anterior ventricular branches 
4. Posterior ventricular branches  (in 10 % of individuals the posterior 
interventricular artery originates from the left coronary artery) 
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LEFT CORONARY ARTERY: 
 The left coronary artery arises from the left posterior aortic sinus of 
the ascending aorta just above the aortic valve The left coronary artery runs 
forward and to the left in between the left auricle and the pulmonary trunk. 
It then divides into two branches namely the anterior interventricular and 
the circumflex branches. 
 The anterior interventricular artery descends in the anterior 
interventricular groove to reach the apex. It then winds round the apex to 
terminate by anastomosing with the posterior interventricular branch of the 
right coronary artery 
BRANCHES OF LCA: 
1. Left anterior descending artery 
2. Circumflex artery 
3. Diagonal artery 
4. Conus artery 
5. Atrial branches 
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ARTERIAL SUPPLY 
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PATHWAY OF BLOOD THROUGH HEART 
 
                                             VENOUS CIRCULATION 
 
VENACAVAE 
 
RIGHT ATRIUM 
 
RIGHT VENTRICLE 
 
PULMONARY CIRCULATION 
 
LEFT ATRIUM 
 
LEFT VENTRICLE 
 
SYSTEMIC CIRCULATION 
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CONDUCTION SYSTEM OF THE HEART: 
The conduction system of the heart comprises of: 
1. Sinoatrial node 
2. AV node 
3. Bundle of His 
4. Bundle branches 
5. Purkinje fibres 
 
SINOATRIAL NODE: 
 
SA node is a spindle shaped structure composed of fibrous tissue 
matrix  with closely packed cells. SA node is located in the lateral wall of 
the epicardium of right atrium at the junction of the superior venacava and 
right atrium.  It is called as the pacemaker of the heart since it is the site 
for impulse generation.  
 
 The SA node is supplied by the branches of  right coronary artery in 
55-60% of hearts. In around 40-45% of population SA node is supplied 
by left circumflex artery. The SA node is innervated richly with 
parasympathetic and sympathetic nerves. 
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CONDUCTION SYSTEM 
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INTERNODAL AND INTRA ATRIAL CONDUCTION: 
Internodal conduction pathways consists of three tracts- 
1. Anterior internodal tract 
2. Middle internodal tract 
3. Posterior intermodal tract 
 
ATRIOVENTRICULAR NODE: 
 AV node is located beneath the endocardium of right atrium just 
anterior to the ostium of the coronary sinus. It is present just above the 
insertion of the septal leaflet of the tricuspid valve. 
 The AV Node is supplied by right coronary artery in 85-90% of 
individuals whereas in the remaining 10-15% it is supplied by the left 
circumflex coronary artery. The main function of the AV node is to delay 
the impulse which is getting transmitted to the ventricles to coordinate the 
contraction of atrium and ventricle. The lower part of the AV node has 
properties of automaticity so that it can act as pacemaker in case of disease 
of the SA node. 
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BUNDLE OF HIS: 
 It is a part of conduction system that connects lower part of AV node 
with the bundle branches. 
 
BUNDLE BRANCH: 
 The right bundle branch is unbranched and it continues 
intramyocardially to the right side of the interventricular septum to reach 
the apex of the right ventricle and base of the anterior papillary muscle. 
The anatomy of the left bundle branch is variable. Usually it is divided into 
anterior and posterior fascicle. 
 
 
PURKINJE FIBRES:  
 These form the interweaving networks connecting bundle branches 
and endocardial surface of both the ventricles. Purkinje fibres in 
comparison with the myocardial tissues are more resistant to ischemia. 
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ENHANCED AUTOMATICITY: 
1. Fever  
2. Hyperthyroidism 
3. Catecholamine release 
4. Medications 
 
          DECREASED AUTOMATICITY: 
1. Increased vagal tone 
2. Endocarditis 
3. Degeneration 
4. Obstructive sleep apnea 
5. Fibrosis 
6. Valvular heart disease 
7. Myocarditis 
8. Genetic 
9. Immunologic 
10. Following cardiac surgery 
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MYOCARDIAL INFARCTION: 
 Myocardial infarction in general indicates the death of the cardiac 
muscle tissue due to deficient blood supply. The most common cause for 
myocardial infarction is thrombus formation over the ruptured plaque in 
the epicardial coronary artery thereby causing reduction in blood supply to 
the myocardium. Hence atherosclerosis remains the most common cause 
for myocardial infarction. 
Other causes that can cause myocardial infarction are- 
1. Fixed coronary artery stenosis 
2. Coronary Vasospasm 
3. Vasculitis 
4. Anomalous origin of coronary artery 
5. Drug use( cocaine, amphetamine ) 
6. Conditions of increased oxygen demand like fever, exertion and 
hyperthyroidism 
7. Conditions that decrease oxygen delivery to tissues like severe 
anemia 
8. Involvement of coronary arteries in case of aortic dissection 
9. Acute pulmonary disorders 
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  MYOCARDIAL INFARCTION IN PEDIATRIC POPULATION: 
1. Kawasaki disease 
2. Takayasu arteritis 
3. Marfan syndrome 
4. Cystic medial necrosis 
5. Progeria 
 
SYMPTOMS OF MYOCARDIAL INFARCTION: 
1. Chest pain 
2. Palpitation 
3. Excessive sweating 
4. Breathlessness 
5. Syncope 
6. Fatigue 
7. Abdominal pain (inferior wall involvement) 
 Acute coronary syndrome is a condition of acute myocardial 
ischemia which comprises of 
1. Unstable angina 
2. NSTEMI 
3. STEMI 
21 
 
 These three conditions are differentiated from each other by the 
findings of ischemia in ECG and elevation of cardiac biomarkers in the 
blood. 
 
RISK FACTORS: 
MODIFIABLE RISK FACTORS: 
1. Dyslipidemia 
2. Smoking 
3. Hypertension 
4. Diabetes mellitus 
5. Obesity 
 
NON MODIFIABLE RISK FACTORS: 
1. Male sex 
2. Family history 
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PATHOLOGICAL CHANGES IN MYOCARDIAL INFARCTION: 
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KILLIPS CLASSIFICATION OF MYOCRADIAL INFARCTION 
CLASS 1- No signs of heart failure 
CLASS 2- Individuals with basal rales or crackles in the lungs + s3 
gallop + elevated JVP 
CLASS 3- Extensive pulmonary edema 
CLASS 4- Individuals with cardiogenic shock or hypotension(SBP< 90 
mmHg), evidence of low cardiac output in the form of oliguria, cyanosis 
or altered mental status. 
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SITES OF OCCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
COMMON SITES OF OCCLUSION IN HEART: 
 
1. Left anterior descending artery 
 
2. Right coronary artery 
 
3. Left circumflex artery 
 
 
BASED ON CLINICAL CRITERIA: 
 
  
TYPE 1-  Ischemia caused by primary coronary event either occlusion or 
thrombosis leading to spontaneous MI   
TYPE 2-  Due to disparity of blood supply and demand leading to 
ischemia   
TYPE 3-  Sudden cardiac death due to MI   
TYPE 4-  MI related to PCI   
TYPE 4A-  In stent thrombosis   
TYPE 5-  MI plus CABG 
Pathologic diagnosis of myocardial infarction is based on evidence 
of myocardial cell death by ischemia. The Features include coagulation 
necrosis and myocytolysis. Stages of myocardial infarction include 
infarction, inflammation, clearance of necrotic debris, repair and scar 
formation. 
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PHYSICAL EXAMINATION: 
1. Tachycardia and Hypertension(anterior wall infarction) 
2. Bradycardia and hypotension (inferior wall infarction) 
3. Tachypnoea 
4. Restlessness 
5. S3, s4 
6. Muffled 1st sound 
7. Paradoxical splitting of 2nd sound 
8. A transient mid/late systolic apical murmur 
9. Fever 
10. Pericardial friction rub 
  DIAGNOSIS OF STEMI: 
1. Electrocardiogram 
2. Serum cardiac biomarkers 
3. Cardiac imaging 
4. Non specific indices of tissue necrosis and inflammation 
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ELECTRO CARDIOGRAM: 
In myocardial infarction When a coronary artery gets occluded due 
to any cause, there will be a sequence of ECG changes which will indicate 
that the myocardial tissue has undergone infarction. The sequential ECG 
changes are- 
 
HYPERACUTE T WAVE IN MI 
1. Hyperacute or peaked T wave 
1. ST segment elevation 
2. Changes involving the QRS complex- formation of pathological 
Q waves, decrease in the size or amplitude of R wave 
3. ST and T Wave changes 
28 
 
 
 
ST ELEVATION IN MYOCARDIAL INFARCTION 
 
 
Q WAVES IN MI 
29 
 
PECULIAR ECG CHANGES IN STEMI: 
1. New onset LBBB 
2. ST depression in V1,V2(due to involvement of the posterior 
wall in myocardial infarction there appears the mirror image in 
the anterior leads) 
3. ST elevation in right sided leads in right ventricular wall MI 
 
NEW ONSET LBBB IN MI 
30 
 
 
 
POSTEROINFERIOR MI 
 
 
RIGHT VENTRICULAR WALL MI 
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SERUM CARDIAC BIOMARKERS: 
CK-MB: 
Creatine kinase has three isoforms- CK-MM, CK-MB, CK-BB Of 
these CK-MB elevation is seen in MI. This enzyme begins to rise at 2-4 
hrs following infarction. Peaks in 24 hrs and reaches the baseline by 48-72 
hrs. This enzyme is utilized in the diagnosis of re-infarction. 
 
TROPONIN I AND T: 
Troponins are proteins that mediate contraction of cardiac and 
skeletal muscle through calcium mediated mechanism. Troponin I is more 
important in myocardial infarction. It begins to rise by 2-4 hrs, reaches 
peak at 48 hrs and returns to baseline by 7-10 days Enzymes like AST, 
LDH and myoglobin also rise during myocardial infarction. 
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TREATMENT: 
1. Primary PCI 
2. Fibrinolysis 
3. Rescue PCI 
4. Antithrombotic therapy- Heparin, Aspirin, clopidogrel 
5. Beta blockers 
6. ACE inhibitors 
7. Nitrates 
 
COMPLICATIONS OF MI: 
1. Ventricular dysfunction 
2. Cardiogenic shock 
3. Right ventricular infarction 
4. Arrhythmias 
5. AV block 
6. Ventricular septal rupture 
7. Acute mitral regurgitation 
8. Left ventricular aneurysm 
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CHOLINESTERASE: 
Cholinesterase are enzymes that has the ability to hydrolyze Acetyl 
choline to choline and acetyl coA 
It is of two types: 
1. Acetyl cholinesterase(true cholinesterase) 
2. Butyryl cholinesterase(pseudocholinesterase) 
 
ACETYL CHOLINESTERASE: 
It has high affinity to degrade acetylcholine. It is present mainly in 
the erythrocytes, neuromuscular junction and neural synapses. 
These enzymes are necessary for proper coordinated contraction and 
relaxation of muscles. In neuromuscular junction, these enzymes degrades 
the excess acetyl choline that is liberated into the NMJ. This makes limited 
muscle contraction as desired by the individual. 
 
BUTYRYL CHOLINESTERASE: 
It is otherwise called as pseudocholinesterase/ serum cholinesterase. 
Though it can degrade acetyl choline, it has higher affinity to bind 
and degrade butyryl choline and hence the name. it is produced mainly by 
the liver and is present in large amounts in the plasma. 
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CHOLINESTERASE IN PLASMA: 
Cholinesterase in plasma is contributed by both acetyl cholinesterase 
and butyryl cholinesterase. Since majority is contributed by butyryl 
cholinesterase the term plasma/ serum cholinesterase is widely applied to 
butyryl cholinesterase. The normal serum cholinesterases in the plasma 
ranges from 4000 to 14000 units. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
MATERIALS AND METHODS 
 
DETAILED STUDY PROPOSAL: 
 
BASIS OF THE STUDY 
 The main goal of this study was to evaluate the level of serum 
cholinesterase in Acute myocardial infarction and its prognostic 
significance 
 Serum cholinesterase level in myocardial infarction decreases after 
12 hours of onset of symptom probably due to decreased synthesis 
of enzyme due to hypoxic condition of the liver or there may be more 
peripheral utilization of this enzyme. 
 An earlier and persistent fall in the serum cholinesterase level 
assessed on the day of admission, day 3, day 5 indicates poor 
prognosis. 
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AIM OF THE STUDY 
 
 To study the incidence, levels and patterns of serum cholinesterase 
activity in acute myocardial infarction. 
 To assess the relationship between the rise and fall of serum 
cholinesterase in myocardial infarction 
 To determine the prognosis with relation to changing trend of serum 
cholinesterase 
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DESIGN OF STUDY 
 Observational prospective study 
PERIOD OF STUDY 
 Feb 2018 to July 2018 
INCLUSION CRITERIA 
 All patients with Acute ST elevation myocardial infarction 
EXCLUSION CRITERIA 
 Patients with onset of symptom(chest pain) >48 hours 
 Liver disease(hepatitis, cirrhosis, malignancy) 
 Malignancies 
 Chronic renal failure 
 Dermatomyositis 
 Nephrotic syndrome 
 Toxic goitre 
 Patients receiving sympathomimetic drug, phenothiazine derivative 
and atropine or its analogues 
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LABORATORY INVESTIGATION 
 Complete blood count 
 Random blood sugar 
 Renal function test 
 Liver function test 
 Electrocardiogram 
 Echo cardiogram 
 Creatine phosphokinase 
 Thyroid stimulating hormone 
 
ANTICIPATED OUTCOME 
 Serum cholinesterase level begins to fall after 12 hours of onset of 
symptoms 
 An Earlier and persistent fall in serum cholinesterase level indicates 
grave prognosis.   
 
 
 
 
 
40 
 
COLLABORATING DEPARTMENTS: 
Department of Cardiology 
Department of Biochemistry 
ETHICAL CLEARANCE:  Obtained 
CONSENT: Individual written and informed consent 
ANALYSIS: Statistical analysis- CHI SQUARE ANALYSIS 
CONFLICT OF INTEREST: Nil 
FINANCIAL SUPPORT: Self 
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RESULTS AND OBSERVATION 
 
TABLE 1- AGE DISTRIBUTION AMONG MI PATIENTS 
Age No Of Cases 
< 40 
6 
41 – 50 
34 
51 – 60 
26 
61 – 70 
22 
> 70 
12 
Total 100 
 
COMMENTS:  
Among 100 patients of myocardial infarction, most of them are 
middle aged with 6 cases of age <40, 34 cases in age group of 41-50, 26 
cases were in the age group of 51-60, 22 cases were in the age group of 61-
70, 12 cases were in the age group of >70. 
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TABLE- 2     SEX DISTRIBUTION IN MI PATIENTS 
 
 
 
 
 
 
 
COMMENTS:  
Among 100 cases in this study majority were males. Out of 100 
cases, 72 cases were males and the remaining 28 were females. This 
shows that myocardial infarction is predominant in male population 
 
 
 
 
 
 
 
 
 
Sex No Of Cases 
Male 72 
Female 28 
Total 100 
44 
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TABLE-3  ALCOHOL CONSUMPTION AMONG MI PATIENTS 
 
 
 
 
 
 
 
Among 100 people diagnosed as myocardial infarction, 57 cases 
were alcoholic and the remaining 43 were non- alcoholic 
 
 
 
 
 
 
 
 
 
 
 
Alcoholic No Of Cases 
Yes 57 
No 43 
Total 100 
46 
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TABLE-4  SMOKING AMONG MI PATIENTS 
 
 
Smokers No Of Cases 
Yes 58 
No 42 
Total 100 
 
 
Among 100 cases who were taken up for the study the distribution 
of smoking was found. About 58 cases were found to have the habit of 
smoking. The remaining 42 cases were non- smokers. 
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TABLE-5 BMI DISTRIBUTION AMONG MI PATIENTS 
 
BMI No Of Cases 
< 20 7 
20 – 24 45 
25 – 29 38 
> 29 10 
Total 100 
 
 
Among 100 cases the distribution of BMI  was studied. About 7 
cases had the BMI of <20, 45 cases had the BMI of 20-24, 38 cases had the 
BMI of 25-29, 10 cases had the BMI of >29 
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TABLE-6 AGE VS SERUM CHOLINESTERASE IN MI 
 
Age 
S.Cholinesterase 
Level 
S.D P'value 
< 40 3323.2 1536.6   
41 – 50 3969.9 1267.0   
51 – 60 3398.9 1209.0   
61 – 70 3528.2 1254.3   
> 70 3359.1 1230.6 0.364 
   
Not 
significant 
 
The serum cholinesterase level was compared with the age among 
myocardial infarction patients. Age is found to be an insignificant factor 
when compared with the level of serum cholinesterase and the statistical 
analysis shows that there appears no significant association between age 
and cholinesterase level  
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TABLE-7 SEX VS CHOLINESTERASE LEVEL 
 
Sex S.Cholinesterase Level S.D P'value 
Male 3639.7 1283.3   
Female 3541.3 1230.1 0.728 
   
Not 
significant 
 
Among myocardial infarction patients, the sex of the individuals 
were compared with the level of cholinesterase which did not show any 
statistical significance on analysis 
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TABLE-8 ALCOHOL VS CHOLINESTERASE 
 
Among 100 patients of myocardial infarction serum cholinesterase 
level was compared between two groups namely alcoholic and non-
alcoholic which showed no significance on statistical analysis 
 
 
 
 
 
 
 
 
 
Alcoholic 
S.Cholinesterase 
Level S.D P'value 
Yes 3859.1 1308.6   
No 3284.8 1133.8 0.741 
   
Not 
Significant 
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TABLE-9 SMOKER VS CHOLINESTERASE 
 
 
 
Among 100 cases of myocardial infarction patients, the level of 
serum cholinesterase was compared between the smoker and non-smoker 
which showed no statistical significance 
 
 
 
 
 
 
 
 
 
 
Smokers S.Cholinesterase Level S.D P'value 
Yes 3644.9 1326.0   
No 3566.9 1185.4 0.762 
   Not sig 
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3520.0
3540.0
3560.0
3580.0
3600.0
3620.0
3640.0
3660.0
Yes No
3644.9
3566.9
SMOKERS VS S.Cholinesterase Level
S.Cholinesterase Level
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TABLE-10 BMI VS CHOLINESTERASE 
 
 
Among 100 myocardial infarction patients, the BMI was compared 
with the serum cholinesterase level and the statistical analysis shows no 
significant association between the BMI and cholinesterase level 
 
 
 
 
 
 
 
 
 
 
BMI S.Cholinesterase Level S.D P'value 
< 20 3216.0 1305.0   
20 – 24 3744.8 1270.6   
25 – 29 3609.1 1243.3   
> 29 3304.4 1361.6 0.626 
   Not sig 
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TABLE-11 DISTRIBUTION OF MAJOR ADVERSE CARDIAC 
EVENTS (MACE) 
 
 
 
 
 
 
 
 
Major adverse cardiac events involves conditions like mortality, 
heart block, ejection fraction <35% as determined by ECHO and 
arrhythmias. 
Based upon the presence or absence of MACE, the myocardial 
infarction patients were categorized as  complicated and uncomplicated 
groups. The presence of MACE indicates complicated group and the 
absence indicates uncomplicated group.  
 
 
 
 
 
MACE NUMBER 
Arrhythmia 12 
EF<35 18 
HB 10 
DEATH 22 
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TABLE-12 COMPLICATED VS UNCOMPLICATED GROUP 
 
 
 
 
 
 
 
 
 
Depending upon the presence or absence of MACE, myocardial 
infarction patients were categorized into 2 groups namely complicated and 
uncomplicated group. In our study about 62 cases were included in the 
complicated group due to the occurrence of MACE. The remaining 32 were 
categorized as uncomplicated since there were no MACE events. 
 
 
 
 
 
 
 
 
Complication No Of Cases 
Complicated 62 
Uncomplicated 38 
Total 100 
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62
38
COMPLICATION
Complicated Uncomplicated
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TABLE-13 CHOLINESTERASE LEVEL IN COMPLICATED AND 
UNCOMPLICATED GROUP 
 
Complication S.Cholinesterase Level S.D P'value 
Complicated 2712.2 565.0   
Uncomplicated 5080.6 414.3 <0.001 
   Significant 
 
On comparing the mean of cholinesterase level in complicated and 
uncomplicated group it is found that the level of cholinesterase level falls 
significantly in the complicated group than the individuals grouped into the 
uncomplicated group. The range of normal serum cholinesterase depends 
upon the laboratory standard. Here the normal value ranges from 4000 to 
14000 units. This indicates that the decrease in cholinesterase level below 
normal following myocardial infarction is associated with complications 
in the form of mortality, EF<35%, Arrhythmias, heart block. 
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TABLE- 14 CHOLINESTERASE LEVEL ON ADMISSION, DAY-
3,DAY-5 
S.Cholinesterase 
Level 
At 
Admission Day 3 Day 5  
Complicated 3509.0 2208.5 2712.2 
< 0.001 
Significant 
Uncomplicated 5010.4 3508.5 5080.6  
 
 
 The level of cholinesterase in myocardial infarction patients in 
complicated group was persistently low on the day of admission, day-3 and 
day-5 as opposed to the normal or higher range of serum cholinesterase 
level in the uncomplicated group. 
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DISCUSSION 
 
 Myocardial infarction is one of the leading cause of mortality and 
morbidity in the world. Myocardial infarction is the death of cardiac 
muscle due to the compromised blood supply. The compromise in blood 
supply may be of atherosclerotic or non-atherosclerotic etiology. However 
atherosclerotic etiology predominates as the leading cause. 
 Various modalities of investigation are available for detecting 
myocardial infarction and also for determining prognosis. ECG showing 
extensive involvement, rise of CPK-MB, cardiogenic shock indicates poor 
prognosis of the patient. Many other parameters are being developed 
recently for determining the prognosis.  
Previously Manoj et al has done a study in Saraswathi institute of 
medical sciences, Uttar Pradesh and found that association existed between 
serum cholinesterase level and the outcome of Myocardial infarction. 
Maarti Oka et al studied the trend of serum cholinesterase in 
myocardial infarction and concluded that fall in serum cholinesterase level 
indicated a bad prognostic sign 
Charles B Moore et al studied the reason for decrease in serum 
cholinesterase and concluded that stress could be the factor causing 
decrease in serum cholinesterase 
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Basu et al found that decrease in serum cholinesterase occurs in 
myocardial infarction and it is predominantly on day 1 of MI 
In this study, 100 cases of myocardial infarction were considered 
and the trend of serum cholinesterase level was monitored on the day of 
admission, day1 and day3. The level of serum cholinesterase level was 
compared with the outcome of the disease. 
The study was carried out in Government Rajaji Hospital wherein 
100 cases of acute ST elevation myocardial infarction were included in the 
study. Age, sex, alcoholic/ smoking, BMI for each patients were assessed. 
Routine investigations were done along with ECG and ECHO. Patients 
were closely monitored and treatment according to the guidelines were 
done. The level of serum cholinesterase was done on the day of admission, 
day 3 and day 5. The decreasing/ increasing trend of serum cholinesterase 
were determined. At the end of 7th day ECG, ECHO were done and patients 
reassessed. The group of patients who had significant fall in the serum 
cholinesterase level had poor outcome in the form of MACE. 
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1) Among 100 patients of myocardial infarction, most of them are 
middle aged with 6 cases of age <40, 34 cases in age group of 41-
50, 26 cases were in the age group of 51-60, 22 cases were in the age 
group of 61-70, 12 cases were in the age group of >70. Age is not 
significantly related to cholinesterase level 
2) Among 100 cases in this study majority were males. Out of 100 
cases, 72 cases were males and the remaining 28 were females. This 
shows that myocardial infarction is predominant in male population. 
Sex does not influence the level of cholinesterase 
3) Among 100 people diagnosed as myocardial infarction, 57 cases 
were alcoholic and the remaining 43 were non- alcoholic. Unless the 
patient is not suffering from alcoholic liver disease, the alcohol 
consumption does not affect the level of cholinesterase 
4) Among 100 cases who were taken up for the study the distribution 
of smoking was found. About 58 cases were found to have the habit 
of smoking. The remaining 42 cases were non- smokers. Smoking 
does not significantly affect the level of cholinesterase. 
5) Among 100 cases the distribution of BMI  was studied. About 7 
cases had the BMI of <20, 45 cases had the BMI of 20-24, 38 cases 
had the BMI of 25-29, 10 cases had the BMI of >29. The level of 
cholinesterase has no significant association with regards to body 
mass index. 
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6) Major adverse cardiac events involves conditions like mortality, 
heart block, ejection fraction <35% as determined by ECHO and 
arrhythmias. 
7) Based upon the presence or absence of MACE, the myocardial 
infarction patients were categorized as  complicated and 
uncomplicated groups. The presence of MACE indicates 
complicated group and the absence indicates uncomplicated group.  
8) Depending upon the presence or absence of MACE, myocardial 
infarction patients were categorized into 2 groups namely 
complicated and uncomplicated group. In our study about 62 cases 
were included in the complicated group due to the occurrence of 
MACE. The remaining 32 were categorized as uncomplicated since 
there were no MACE events. 
9) On comparing the mean of cholinesterase level in complicated and 
uncomplicated group it is found that the level of cholinesterase level 
falls significantly in the complicated group than the individuals 
grouped into the uncomplicated group. This indicates that the 
decrease in cholinesterase level below normal following myocardial 
infarction is associated with complications in the form of mortality, 
EF<35%, Arrhythmias, heart block 
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REASON FOR DECREASE IN CHOLINESTERASE LEVEL IN MI: 
Acute myocardial infarction will cause initial sympathetic 
stimulation which will later be compensated by the rise in parasympathetic 
activity. Increase in parasympathetic activity causes increase in 
acetylcholine level in the heart which diffuses into the circulation through 
damaged myocyte. The released acetyl choline are utilized by the serum 
cholinesterase and hence the value of serum cholinesterase decreases. As 
long as the parasympathetic activity persists there will be persistent fall in 
serum cholinesterase level which will lead to poor outcome. 
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1. The serum cholinesterase level was measured among myocardial 
infarction patients on the day of admission, on day 3, day 5 and the 
patient was followed up for the outcome at the end of 7th day by 
reassessing the ECG, ECHO and by clinical examination.  
2. Those group of patients whose serum cholinesterase level was 
reduced on admission, day 3, day 5 had poor outcomes with the 
presence of MACE. The cholinesterase level had significant fall and 
this correlated significantly with the poor outcome. 
3. Each value measured on day of admission, day 3 and day 5 
separately had significant correlation with the poor outcome which 
were categorized into complicated group. 
4. The Earlier and significant fall in serum cholinesterase level 
indicates poor prognosis in the myocardial infarction patients and 
this could be used as a marker to predict prognosis. 
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CONCLUSION 
 
 Myocardial infarction being a dreadful disease is one of the leading 
cause of death in the world. In this study conducted in Government Rajaji 
Hospital, 2018 has compared the level of serum cholinesterase with the 
outcome of myocardial infarction. Various suspected confounding factors 
were also considered and they were compared with the level of 
cholinesterase and statistical analysis were done. Factors like Age, sex, 
alcoholic, smoking, BMI were compared with serum cholinesterase and 
none had a significant correlation. 
The patients who had persistent fall in the serum cholinesterase level 
had poor prognostic outcome in the form of experiencing major adverse 
cardiac events. The level of serum cholinesterase level was compared 
between the complicated and uncomplicated group and found that patients 
in complicated group had significant fall in the serum cholinesterase 
measured on the day of admission, day 3 and day 5. Hence fall in serum 
cholinesterase level can be used as a poor prognostic indicator in ST 
elevation acute myocardial infarction. 
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SUMMARY 
 
In Government Rajaji hospital, Madurai a prospective observational 
study was carried out involving 100 patients of Acute Myocardial 
infarction. Patients were followed up with the values of serum 
cholinesterases on the day of admission, day 3 and day 5. On the 7th day 
they were reassessed and the outcome was quantified. It was found that 
those patients who had MACE categorized into complicated group had a 
significant fall in the serum cholinesterase level. This concludes that those 
patients whose serum cholinesterase level falls early will have poor 
outcome irrespective of the age, sex, alcoholism, smoking, BMI. 
Hence serum cholinesterase can be used as an early marker in 
determining prognosis in case of Acute ST elevation myocardial infarction. 
This has proved the previous studies and ascertains the importance of 
measuring serum cholinesterase level in myocardial infarction. 
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PROFORMA 
 
PARTICULARS OF THE PATIENT:  
Name:   
Case no:  
Age/ Sex:  
I.P. no:  
Address:  
 Date of admission:  
Date of discharge:  
Final diagnosis:  
COMPLAINTS WITH DURATION:  
  
 Past history: DM Y/N                  HTN Y/N                            CAD Y/N                                    
CVA Y/N                 CKD Y/N                            
                     MALIGNANCY Y/N         ATT Y/N  
 Personal history: SMOKING Y/N                     ALCOHOL Y/N  
Family history:  
On Examination,   
Vital signs          Pulse:                            B.P.:                                     R.R.:  
SpO2:                              Temperature:  
  
CVS:  
RS:  
ABDOMEN: CNS:  
INVESTIGATION:  
 RBS  
UREA  
CREATININE 
LFT  
TOTAL CHOLESTEROL  
 TOTAL COUNT  
 DIFFERENTIAL COUNT  
ECG  
TROPONIN I  
URINE R/E  
ECHO:   
PATIENT OUTCOME: 
 
 
    
 
ABBREVIATIONS 
 
ECG- Electrocardiogram 
STEMI- ST elevation myocardial infarction 
NSTEMI- Non ST elevation myocardial infarction 
SA node- Sinoatrial node 
AV node- Atrioventricular node 
JVP- Jugular venous pulse 
SBP- Systolic blood pressure 
MI- Myocardial infarction 
PCI- Percutaneous coronary intervention 
CABG- Coronary artery bypass graft 
LBBB- left bundle branch block 
CK- Creatine kinase 
AST- Aspartate Transaminase 
LDH- Lactate dehydrogenase 
ACE- Angiotensin converting enzyme 
NMJ- Neuromuscular junction 
BMI- Body mass index 
MACE- Major adverse cardiac events 
EF- Ejection fraction 
HB- Heart block 
Sex Alcohalic Smoker BMI Complicated At Admission Day 3 Day 5 MACE
1 71 M Y 23 C 3600 2248 2248 yes
2 60 M Y Y 20 C 3680 2045 3215 yes
3 76 M Y 28 UC 4598 3564 4258 No
4 33 M Y Y 16 C 3156 2078 2457 Yes
5 77 F 32 C 3246 2457 2140 Yes
6 61 M Y Y 26 C 3345 2140 2469 Yes
7 49 M Y Y 20 C 3258 2469 2075 Yes
8 61 F 21 UC 4258 3698 4563 No
9 45 M Y Y 29 C 3760 2075 2145 Yes
10 62 F 17 UC 4569 3478 5598 No
11 58 M Y Y 30 C 3596 2069 2087 yes
12 62 M 40 UC 4785 3654 4789 No
13 73 M Y 26 C 3845 2145 2456 yes
14 48 F 28 UC 4125 3214 5698 No
15 63 M Y Y 22 C 3956 2365 2413 yes
16 57 F 30 C 3482 2087 3150 yes
17 35 M Y Y 33 C 3587 2497 2365 yes
18 66 M 19 C 3654 2456 2145 yes
19 59 M Y 24 UC 4365 3569 4879 No
20 64 M Y Y 25 C 3892 2365 2159 yes
21 47 F 23 C 3541 2413 3254 yes
22 64 M Y Y 29 UC 4254 3654 5496 No
23 56 M Y Y 28 C 3965 2069 3147 yes
24 32 F 24 UC 5698 3658 5781 No
25 66 M Y Y 17 C 3458 2365 2365 yes
26 77 M Y 26 C 3874 2145 3251 yes
27 50 M Y 23 C 3654 2368 2468 yes
28 42 M Y Y 23 UC 5234 3458 4896 No
29 75 M Y Y 24 UC 5241 3621 5398 No
30 56 F 25 C 3215 2159 3514 yes
31 33 M Y Y 28 UC 5698 3489 4736 No
32 67 M Y Y 22 C 3854 2043 2365 yes
33 45 F 29 C 3698 2158 2147 yes
34 55 M Y Y 27 UC 5213 3215 5980 No
35 65 M Y Y 24 C 3487 2036 2369 yes
36 54 M Y 21 C 3521 2145 3612 yes
37 40 F 28 UC 5264 3987 4563 No
38 56 M Y Y 30 UC 5365 3572 5124 No
39 57 F 23 C 3698 2365 2159 yes
40 68 M Y 22 UC 5145 3698 4896 No
41 41 M Y 28 C 3452 2017 2214 yes
42 65 F 23 C 3547 2468 2108 yes
43 53 M Y Y 26 C 3954 2489 3150 yes
44 69 M Y 18 UC 5246 3146 4269 No
45 35 M Y Y 24 C 3547 2368 2354 yes
46 66 F 21 C 3165 2013 3214 yes
S.Cholinesterase Level
S.No Age
47 42 M Y Y 23 UC 5365 3012 4896 No
48 58 F 22 C 3201 2478 2106 yes
49 49 M Y Y 26 UC 5241 3250 5698 No
50 67 M Y Y 24 UC 5321 3478 4598 No
51 37 F 19 C 3264 2365 2246 yes
52 51 F 29 C 3641 2147 2278 yes
53 49 M Y Y 26 C 3241 2069 2145 yes
54 52 M Y 28 C 3321 2369 2156 yes
55 68 M Y Y 24 UC 5243 3520 5698 No
56 47 M Y 24 UC 5364 3652 4985 No
57 54 M Y 28 C 3214 2048 2147 yes
58 48 F 24 UC 5234 3698 4963 No
59 56 M Y Y 35 C 3342 2353 3102 yes
60 46 M Y 24 C 3571 2037 2146 yes
61 41 F 23 C 3421 2159 3480 yes
62 57 M Y Y 30 C 3212 2069 2154 yes
63 45 M Y Y 21 C 3321 2214 3314 yes
64 67 M Y 29 C 3501 2108 3504 yes
65 47 M Y Y 28 UC 5145 3025 5123 No
66 46 M Y Y 24 UC 4569 3658 5361 No
67 58 F 20 C 3314 2074 3158 yes
68 46 M Y 27 UC 5476 3450 4963 No
69 74 M Y Y 27 C 3504 2156 3256 yes
70 40 F 18 C 3611 2354 3432 yes
71 59 M Y Y 23 UC 4256 3412 4789 No
72 47 M Y 26 C 3245 2056 3652 yes
73 57 M 21 C 3158 2471 3421 yes
74 45 M Y Y 37 UC 5214 3354 5632 No
75 69 M Y Y 28 C 3147 2106 3812 yes
76 43 F 24 C 3256 2165 3412 yes
77 82 M Y Y 28 UC 4127 3216 5124 No
78 48 M Y 29 C 3432 2145 3625 yes
79 59 F 26 C 3521 2246 3541 yes
80 47 M Y Y 21 UC 4589 3982 5362 No
81 49 M Y Y 28 C 3652 2278 3745 yes
82 64 F 23 C 3421 2145 3211 yes
83 42 M Y Y 29 UC 5647 3045 4963 No
84 54 M Y Y 26 C 3684 2156 2440 yes
85 73 F 22 UC 4521 3201 4879 No
86 43 M Y Y 28 UC 4698 3650 4698 No
87 73 M Y 38 C 3812 2248 2501 yes
88 55 F 25 C 3412 2041 2465 yes
89 41 M Y Y 24 UC 5879 3987 4852 No
90 62 M Y Y 21 C 3521 2147 2365 yes
91 40 M 29 C 3625 2168 2543 yes
92 56 M Y Y 22 UC 5698 3560 5126 No
93 44 M Y 23 C 3541 2073 2354 yes
94 76 F 21 C 3812 2146 2145 yes
95 42 M Y Y 22 UC 4265 3410 5246 No
96 57 M Y 25 UC 5963 3245 5231 No
97 72 M Y 29 C 3745 2065 2653 yes
98 42 M Y 20 C 3211 2154 2431 yes
99 58 F Y 20 UC 4258 3988 4987 No
100 43 F Y 24 UC 5264 3854 4963 No
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